Amphastar subsidiary enters exclusive Primatene MIST distribution deal for Greater China; est. $10M over 10 yrs

Amphastar Pharmaceuticals, Inc.

Armstrong (Amphastar subsidiary) appoints Genreach as exclusive distributor for Primatene MIST in Mainland China, Taiwan, Hong Kong, Macau; 10-year term.
Estimated total revenue to Amphastar over 10 years is ~$10 million, subject to currency exchange adjustments.
Genreach is responsible for obtaining all regulatory approvals in the region.
Related-party transaction: CEO Jack Zhang and Chairman Mary Luo beneficially own majority of Hanxin, Genreach's parent.
Minimum purchase amounts per contract year; profit sharing based on Genreach's per unit net revenue.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.